Formulation and Drug Delivery, Solid Dosage

FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes

September 23, 2019

FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.

Nanoform Invests in Nanoparticle Technology for Drug Development

September 19, 2018

The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.

Sensor Technology Aims to Improve Medication Adherence

March 16, 2018

Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs.

Formulation of Biologics for Non-Invasive Delivery

October 01, 2017

BioPharm International

There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.

Are Oral Peptide Drugs on the Horizon?

July 14, 2016

A new study examines the oral delivery of protein drugs in plant cells and hypothesizes that the cold storage and transportation of biologics could someday be eliminated.

Novo Nordisk to Start Phase IIIa Trials for Oral Biologic

August 26, 2015

The company announced plans to begin PIONEER, a Phase IIIa program comprising seven trials of approximately 8000 people with type 2 diabetes.

FDA Issues Dissolution Testing Guidance

August 03, 2015

FDA issues draft guidance on dissolution testing for immediate-release solid oral dosage forms.

Almac Adds Contained Drug Handling Capabilities

July 16, 2013

Almac's Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products.